Comparison of effects of losartan and metoprolol on left ventricular and aortic function at rest and during exercise in chronic aortic regurgitation

• Published in: The International Journal of Cardiovascular Imaging Vol. 34; no. 4; pp. 615 - 624
• Main Authors: Roberts, Paul A., Lin, Aaron C. W., Cowan, Brett R., Young, Alistair A., Stewart, Ralph
• Format: Journal Article
• Language: English
• Published: Dordrecht Springer Netherlands 01.04.2018; Springer Nature B.V
• Subjects: Aorta; Blood pressure; Cardiac Imaging; Cardiology; Heart diseases; Heart rate; Imaging; Magnetic resonance; Magnetic resonance imaging; Medicine; Medicine & Public Health; Metoprolol; Original Paper; Patients; Physical training; Pressure effects; Radiology; Regurgitation; Rest; Vasodilators; Ventricle; Wave velocity; Regurgitant fraction; Metoprolol; Aortic regurgitation; Aortic distensibility; Losartan
• ISSN: 1569-5794; 1573-0743; 1875-8312
• DOI: 10.1007/s10554-017-1268-y

Aortic regurgitation (AR) increases the hemodynamic load on both the left ventricle (LV) and the aorta. Vasodilators and beta-blockers both reduce systemic blood pressure, but their relative effects on the LV and aortic function and aortic regurgitant fraction in chronic AR are uncertain. We aimed to compare short-term effects of losartan and metoprolol on LV and aortic function in asymptomatic patients with chronic moderate to severe AR, both at rest and during exercise, using cardiac magnetic resonance (CMR) imaging. 17 chronic AR patients were randomized to 4–6 weeks losartan followed by metoprolol, or vice versa, in a cross-over design. Aortic regurgitant fraction, aortic distensibility, pulse wave velocity and LV function were assessed at rest and after moderate exercise stress (29 ± 7 W, heart rate increase 25 ± 6 bpm) using CMR. Chronic AR patients on metoprolol had a significantly lower mean heart rate, cardiac power index and rate-pressure product, than on losartan (all p < 0.01). However, aortic regurgitant fraction was greater on metoprolol compared to losartan (by 7 ± 11%, p = 0.02). Metoprolol was also associated with a greater reduction in aortic distensibility during exercise than losartan (− 2.4 ± 1.5 × 10 −3  vs − 1.7 ± 2.1 × 10 −3  mmHg −1 respectively, p = 0.04). End-diastolic volume index was higher on metoprolol than losartan at exercise (difference 6.6 ± 7.8 ml/m 2 , p < 0.01), as was end-systolic volume index (difference 4.0 ± 5.2 ml/m 2 , p < 0.01). Losartan and metoprolol have significantly different short-term effects on aortic regurgitation and LV and aortic function in chronic AR. Further research is required to determine the long-term clinical significance of these changes.